Early Aspirin Withdrawal After PCI in ACS: NEO-MINDSET and TARGET Trials
Christopher Cannon, Senior Physician in the Cardiovascular Division at Brigham and Women’s Hospital, shared a post on LinkedIn:
”Keep the ASA for the first 12 months post ACS PCI.
The NEO-MINDSET trial found that early stopping and keeping P2Y12 monotherapy was NOT sufficient for efficacy.
Of note, another study published, the TARGET First looked at “low risk” STEMI patients and suggested one could stop ASA, but it appeared to have much less power with just 41 primary endpoints.
So – I will aim to keep DAPT for a year post PCI for ACS. (although sometimes one has to adapt for very high risk bleeding patients).”
Title: Early Withdrawal of Aspirin after PCI in Acute Coronary Syndromes
Authors: Patricia O. Guimarães, Marcelo Franken, Caio A.M. Tavares, Murillo O. Antunes, Fabio S. Silveira, Pedro B. Andrade, Ricardo R. Bergo
Read the full article here.
Find more on Hemostasis Today.
-
Jun 10, 2026, 12:02Sharmila Manian: One Drop of Humanity – Give Blood and Save Lives on June 14
-
Jun 10, 2026, 11:50Tsigereda Bekele: Ischemic Stroke vs. Hemorrhagic Stroke
-
Jun 10, 2026, 07:58Razan Suliman: When do we use sodium citrate instead of EDTA for a CBC?
-
Jun 10, 2026, 07:49Rasha Mohamed Abd El Fattah: Pathophysiology and Modern Treatment of Ischemic Stroke
-
Jun 10, 2026, 06:47Mavis Agnes Kisakye: Proud to Join Forces with Action in Africa to Drive Awareness and Education on Blood Disorders
-
Jun 10, 2026, 06:26Tracy Madsen: Migraine Remains Associated with An Increased Risk of Ischemic Stroke Even After Menopause
-
Jun 10, 2026, 05:29What Happens When Molecular Science and Clinical Insight Move Together? – McMaster University Department of Medicine
-
Jun 10, 2026, 04:58Edward Lee Carter: What If Better Stroke Prevention Didn’t Require More Bleeding?
-
Jun 10, 2026, 04:50Antoine Francis: Plasma as the Internet of the Human Body